Efficacy of paliperidone palmitate 3-month formulation in preventing hospital admissions. 60 months of follow-up
Introduction Paliperidone Palmitate 3-month formulation (PP3M) has shown a significantly longer time to relapse compared to placebo, with similar efficacy and safety to Paliperidone Palmitate 1-month (PP1M). However, studies of longer duration are required. Objectives The main objective of this st...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Cambridge University Press
2022-06-01
|
| Serija: | European Psychiatry |
| Teme: | |
| Online pristup: | https://www.cambridge.org/core/product/identifier/S0924933822007301/type/journal_article |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|